Literature DB >> 28756077

[The gut microbiota, a new cardiovascular risk factor?]

Caroline Chong-Nguyen1, Henri Duboc2, Harry Sokol3.   

Abstract

The gut microbiota is considered as our other "brain" and is implicated in several regulation of physiological metabolisms. The circulating level of TMAO, a metabolite of the gut microbiota, is directly correlated to the occurrence of cardiovascular events. Bile acids are protective metabolites against cardiovascular diseases through their anti-inflammatory and anti-atherogenic effects. The disturbance in the metabolism and the composition of the gut microbiota is called "dysbiosis". Understanding the implication of the gut microbiota and developing new therapeutic strategies are promising research fields to manage metabolic and cardiovascular diseases.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28756077     DOI: 10.1016/j.lpm.2017.06.005

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

Review 1.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 2.  Influence of gut microbiota dysbiosis on brain function: a systematic review.

Authors:  Cátia Almeida; Rita Oliveira; Raquel Soares; Pedro Barata
Journal:  Porto Biomed J       Date:  2020-03-17

Review 3.  Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?

Authors:  Lin Li; Senjie Zhong; Bin Cheng; Hong Qiu; Zhixi Hu
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-06       Impact factor: 2.629

Review 4.  The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease.

Authors:  Shirley Mei-Sin Tran; M Hasan Mohajeri
Journal:  Nutrients       Date:  2021-02-25       Impact factor: 5.717

5.  Antithrombotic Activity of Heparinoid G2 and Its Derivatives from the Clam Coelomactra antiquata.

Authors:  Guanlan Chen; Rui Zeng; Xin Wang; Hongying Cai; Jiajia Chen; Yingxiong Zhong; Saiyi Zhong; Xuejing Jia
Journal:  Mar Drugs       Date:  2022-01-05       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.